Impact of PCSK9 inhibitors on hemostasis in patients with hypercholesterolemia

M. Basiak,M. Kosowski,M. Hachula,R. Krysiak,B. Okopien

Atherosclerosis（2023）

引用 0|浏览6

暂无评分

摘要

Background and Aims: In addition to lowering plasma lipid levels, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors may have multiple pleiotropic effects unrelated to lipids. This study aimed to evaluate the efficacy of PCSK9 inhibitors in patients with isolated hypercholesterolemia.

查看译文

关键词

pcsk9 inhibitors,hemostasis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要